Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Once a product is placed on import alert, FDA staff may hold incoming shipments without conducting physical testing or inspectiona process known as detention without physical examination or DWPE, as mentioned above
Find out how to get $100 off your first GLP-1 treatment from Regenics Here's how you can get started with Regenics today and see if you're a fit for GLP-1 weight loss treatments
Meals that combine protein, fat, and complex carbohydrates produce a steadier blood sugar response than meals built around a single macronutrient
S Rachakonda, FM, and JJNP analyzed the bulk and single-cell RNA sequencing data
Fatigue on tirzepatide and semaglutide-related fatigue can create a cycle where poor sleep worsens digestive symptoms, digestive discomfort disrupts sleep further, and the combined effect makes side effects harder to tolerate
US$ 29.54
US$ 20.39
US$ 21.86
US$ 26.90
US$ 21.39
US$ 25.34
